The expansion of the naive CART subpopulation was further evaluated by analyzing the evolution of the CD4+ and CD8+ fractions of HDs and untreated CLL patients (Figure 3). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.